Qritive, a provider of AI-powered precise cancer diagnosis solutions for medical professionals, secured Series A funding of $7.5 million (around ₹60 crores).
MassMutual Ventures led the investment round with participation from Seeds Capital and Exfinity Venture Partners.
Including the latest funding round, Qritive has raised more than $10 million in funding to date. The startup previously (in 2019) announced a $1.5 million Seed funding round co-led by SGinnovate and Pix Vine Capital.
According to the company, new funds will be deployed for product and geographical expansions. Founded by Aneesh Sathe and Kaveh Taghipour in 2017, Qritive builds AI-based solutions for cancer diagnosis and enhances imaging accuracy for medical professionals ensuring faster diagnosis.
Investors
MassMutual Ventures is the venture capital arm of US-based insurance firm Massachusetts Mutual Life Insurance Company. The firm has invested more than $300 million in digital health startups to date; its portfolio includes – Biofourmis, HelloBetter, Limelight Health, Picwell, Qure.ai, Vericred, and Xund.
Digital cancer care startups
Digital cancer care startups have attracted $3 million in venture capital funding to date, according to our database.
The latest funding rounds by cancer care startups include:
Xilis, a precision digital cancer care platform that guides treatment decisions for oncologists to improve cancer care outcomes for patients, raised $19 million in Series A extension funding. FPV Ventures led the investment round with participation from Alexandria Venture Investments, EQT Life Sciences, Mubadala Capital Management, Pear Ventures, GV (formerly Google Ventures), Duke Angel Network, Catalio Capital Management, Two Sigma Ventures, Felicis Ventures, and Alix Ventures.
Perception Vision Medical Technologies (PVmed), a provider of AI-guided solutions that help doctors plan and treat cancers precisely, raised $14 million in Series A funding from Cherami Investment Group, Philips, JHF Investment, COCOCAPITAL Corporation, and Strategy Capital.
Aiosyn, a provider of an AI-powered cancer diagnostics and treatment platform for care providers, raised €2 million in funding led by Health Innovations with participation from Oost NL and LUMO Labs.
Fountain Life, an AI-powered precision cancer, heart disease, and dementia diagnostics and treatment platform, raised $15 raised in funding from Eos Venture Partners and Newcross Healthcare.
Ibex Medical Analytics, a provider of AI-powered cancer diagnostic solutions for pathologists, raised $10 million in debt funding led by Kreos Capital, a growth debt capital provider.
OncoPrecision, an AI-powred precision cancer treatment platform for doctors, raised $3.3 million in seed funding from SOSV’s IndieBio, GRIDX, New York Ventures, Creative Ventures, and Fundación Para el Progreso de la Medicina.
